home / stock / xsnx / xsnx quote
Last: | $0.0139 |
---|---|
Change Percent: | 0.0% |
Open: | $0.0139 |
Close: | $0.0139 |
High: | $0.0139 |
Low: | $0.0139 |
Volume: | 80,678 |
Last Trade Date Time: | 07/16/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.0139 | $0.0139 | $0.0139 | $0.0139 | $0.0139 | 80,678 | 07-16-2024 |
$0.0139 | $0.01 | $0.0139 | $0.014 | $0.01 | 102,831 | 07-15-2024 |
$0.013 | $0.01 | $0.013 | $0.013 | $0.01 | 15,300 | 07-12-2024 |
$0.0125 | $0.008 | $0.0125 | $0.0125 | $0.008 | 1,360 | 07-11-2024 |
$0.008 | $0.012 | $0.008 | $0.014 | $0.008 | 51,401 | 07-10-2024 |
$0.014 | $0.01 | $0.014 | $0.014 | $0.01 | 42,503 | 07-09-2024 |
$0.01219 | $0.01219 | $0.01219 | $0.01219 | $0.01219 | 1,000 | 07-08-2024 |
$0.01 | $0.01 | $0.01 | $0.01 | $0.01 | 25,020 | 07-05-2024 |
$0.01 | $0 | $0.01 | $0 | $0 | 8 | 07-03-2024 |
$0.01 | $0.0075 | $0.01 | $0.01 | $0.0075 | 28,111 | 07-01-2024 |
$0.0082 | $0.0082 | $0.0082 | $0.0082 | $0.0082 | 837 | 06-28-2024 |
$0.01 | $0.01 | $0.01 | $0.01 | $0.01 | 50,000 | 06-27-2024 |
$0.008 | $0.008 | $0.008 | $0.008 | $0.008 | 25,756 | 06-26-2024 |
$0.008 | $0.0099 | $0.008 | $0.0118 | $0.008 | 46,104 | 06-25-2024 |
$0.0118 | $0.0118 | $0.0118 | $0.0118 | $0.0118 | 7,004 | 06-24-2024 |
$0.01 | $0.01 | $0.01 | $0.01 | $0.01 | 33,001 | 06-21-2024 |
$0.01063 | $0.011 | $0.01063 | $0.011 | $0.01063 | 104,551 | 06-20-2024 |
$0.012 | $0 | $0.012 | $0 | $0 | 1 | 06-18-2024 |
$0.012 | $0.01225 | $0.012 | $0.01225 | $0.012 | 4,001 | 06-17-2024 |
$0.01225 | $0.0137 | $0.01225 | $0.0137 | $0.01225 | 75,092 | 06-14-2024 |
News, Short Squeeze, Breakout and More Instantly...
CLEVELAND, OH / ACCESSWIRE / May 21, 2024 / NovAccess Global Inc. (OTCQB:XSNX), a pioneering biomedical company developing innovative immunotherapies for brain tumor patients, today announced it has submitted a provisional patent for new intellectual property developed at Cedars-Sinai to advance...
CLEVELAND, OH / ACCESSWIRE / May 7, 2024 / NovAccess Global Inc. (OTCQB:XSNX), a biomedical company developing novel immunotherapies for brain tumor patients, today announced the postponement of its Annual Meeting of Shareholder which was previously scheduled to be held in May 2024. The Company ...
CLEVELAND, OH / ACCESSWIRE / April 30, 2024 / NovAccess Global Inc. (OTCQB:XSNX), a biomedical company developing a novel immunotherapy for patients suffering from cancers of the central nervous system, today announced the procurement of a new intellectual property license from Cedars-Sinai Medi...